AHCO:NSD-AdaptHealth Corp (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 20.97

Change

+0.90 (+4.48)%

Market Cap

USD 1.69B

Volume

0.22M

Average Target Price

USD 25.50 (+21.60%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-09-28 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ALGN Align Technology, Inc

+4.93 (+1.55%)

USD25.05B 14.49 68.43
PODD Insulet Corporation

+3.42 (+1.53%)

USD14.70B 773.39 143.86
LVGO Livongo Health, Inc

-2.85 (-2.03%)

USD14.25B N/A N/A
ABMD Abiomed, Inc

+7.11 (+2.67%)

USD12.00B 75.42 46.69
TNDM Tandem Diabetes Care, Inc

+2.09 (+1.93%)

USD6.60B N/A N/A
BRKR Bruker Corporation

+0.33 (+0.84%)

USD5.99B 36.51 18.69
SDC SmileDirectClub, Inc

+0.27 (+2.40%)

USD4.34B N/A N/A
IART Integra LifeSciences Holdings ..

-0.19 (-0.40%)

USD3.96B 160.06 27.46
WMGI Wright Medical Group N.V

+0.12 (+0.39%)

USD3.95B N/A 62.99
NUVA NuVasive, Inc

-0.06 (-0.12%)

USD2.56B 49.69 17.19

ETFs Containing AHCO

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 90.98% 93% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 90.98% 93% A 91% A-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 1.69B 83% B 77% C+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio -99,999.99 98% A+ 95% A
Price/Book Ratio 227.22 1% F 0% N/A
Price / Cash Flow Ratio 28.01 15% F 11% F
EV/EBITDA 21.84 55% F 32% F
Management Effectiveness  
Return on Equity -19.55% 66% D 36% F
Return on Invested Capital 7.49% 85% B 71% C-
Return on Assets 6.20% 94% A 88% B+
Debt to Equity Ratio -2,721.30% 100% A+ 100% A+
Technical Ratios  
Short Ratio 3.05 58% F 51% F
Short Percent 5.00% 48% F 39% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Negative earnings

The company had negative total earnings in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector